A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Recruiting · NCT07463521 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-10-09 | NCT07463521 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mg0038 10103 | Columbus | United States | 1 |
| Mg0038 10104 | Scottsdale | United States | 1 |
| Mg0038 10105 | O'Fallon | United States | 1 |
| Mg0038 10106 | Amherst | United States | 1 |
| Mg0038 10108 | Greenfield | United States | 1 |
| Mg0038 10201 | Montreal | Canada | 1 |
| Mg0038 20604 | Barcelona | Spain | 1 |
| Mg0038 20605 | Alicante | Spain | 1 |
| Mg0038 20606 | Málaga | Spain | 1 |
| Mg0038 20611 | Madrid | Spain | 1 |
| Mg0038 31802 | Kobe | Japan | 1 |
| Mg0038 31901 | Beijing | China | 1 |
| Mg0038 31902 | Suzhou | China | 1 |
| Mg0038 31906 | Chengdu | China | 1 |
| Mg0038 31907 | Nanchang | China | 1 |